Transcriptome-Based Six-Gene Fatty Acid Metabolism Signature for Prognosis and Predicted Immunotherapy Response in Lung Adenocarcinoma: Cross-Population Validation.

Ma Q, Liang J, Li J, Li J.

Open source

DOI
10.3390/genes17080914
Published
2026-07-31
Container
Genes (Basel)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/genes17080914,
  title = {Transcriptome-Based Six-Gene Fatty Acid Metabolism Signature for Prognosis and Predicted Immunotherapy Response in Lung Adenocarcinoma: Cross-Population Validation.},
  author = {Ma Q and  Liang J and  Li J and  Li J.},
  year = {2026},
  journal = {Genes (Basel)},
  doi = {10.3390/genes17080914},
  url = {https://doi.org/10.3390/genes17080914}
}

RIS

TY  - JOUR
TI  - Transcriptome-Based Six-Gene Fatty Acid Metabolism Signature for Prognosis and Predicted Immunotherapy Response in Lung Adenocarcinoma: Cross-Population Validation.
AU  - Ma Q
AU  -  Liang J
AU  -  Li J
AU  -  Li J.
PY  - 2026
JO  - Genes (Basel)
DO  - 10.3390/genes17080914
UR  - https://doi.org/10.3390/genes17080914
ER  - 

APA

Q, M., J, L., J, L., & J., L. (2026). Transcriptome-Based Six-Gene Fatty Acid Metabolism Signature for Prognosis and Predicted Immunotherapy Response in Lung Adenocarcinoma: Cross-Population Validation.. Genes (Basel). https://doi.org/10.3390/genes17080914

Source records